REVIEW
|
doi:10.20944/preprints202307.0013.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
prostate cancer; PARP inhibitors; DDR gene; CRPC
Online: 3 July 2023 (08:22:22 CEST)
ARTICLE
|
doi:10.20944/preprints202307.0924.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
dmrFABP5, Prostate Cancer, CRPC, Enzalutamide, Docetaxel, Synergic effect.
Online: 13 July 2023 (11:05:11 CEST)
REVIEW
|
doi:10.20944/preprints202104.0287.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
prostate cancer; castrate resistance, non-metastatic CRPC, clinical trial, epithelial mesenchymal transition, STAT3
Online: 12 April 2021 (12:28:10 CEST)